Isolation and functional characterization of the novel clostridium botulinum neurotoxin A8 subtype

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Kull, Skadi ^a,d   Schulz, K Melanie ^a   Strotmeier, Jasmin Weisemannnée ^b   Kirchner, Sebastian ^a,e   Schreiber, Tanja ^a   Bollenbach, Alexander ^b   Dabrowski, P Wojtek ^a   Nitsche, Andreas ^a   Kalb, Suzanne R ^c   Dorner, Martin B ^a   Barr, John R ^c   Rummel, Andreas ^b   Dorner, Brigitte G ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^d RESEARCH CENTER BORSTEL   (Germany)

^e UNIVERSITY OF POTSDAM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN A1; BOTULINUM TOXIN A8; UNCLASSIFIED DRUG; PROTEIN BINDING; RNA 16S;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOLOGICAL ACTIVITY; BOTULISM; CASE REPORT; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; GENE CLUSTER; GENE LOCATION; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; MALE; MIDDLE AGED; MOUSE; NEUROTOXIN GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TOXIN ANALYSIS; CHEMISTRY; CLASSIFICATION; CLOSTRIDIUM BOTULINUM TYPE A; DNA SEQUENCE; EPIDEMIC; GENETICS; GERMANY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOLECULAR MODEL; PATHOLOGY; PRESERVED FOOD;

CLOSTRIDIUM BOTULINUM;

AMINO ACID SEQUENCE; BASE SEQUENCE; BOTULINUM TOXINS, TYPE A; BOTULISM; CLOSTRIDIUM BOTULINUM TYPE A; DISEASE OUTBREAKS; FOOD, PRESERVED; GERMANY; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 84922699990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116381     Document Type: Article

References (96)

1. PeckMW(2009) Biology and genomic analysis of Clostridium botulinum Adv Microb Physiol 55: 183-265, 320. doi: 10.1016/S0065-2911(09)05503-9 PMID: 19573697
2. Rossetto O, Megighian A, Scorzeto M, Montecucco C (2013) Botulinum neurotoxins. Toxicon 67: 31-36. doi: 10.1016/j.toxicon.2013.01.017 PMID: 23435262
3. Popoff MR, Bouvet P (2009) Clostridial toxins. Future Microbiol 4: 1021-1064. doi: 10.2217/fmb.09.72 PMID: 19824793
4. Popoff MR (2014) Botulinum neurotoxins: more and more diverse and fascinating toxic proteins. J Infect Dis 209: 168-169. doi: 10.1093/infdis/jit505 PMID: 24106294
5. Barash JR, Arnon SS (2014) A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis 209: 183-191. doi: 10.1093/infdis/jit449 PMID: 24106296
6. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, et al. (2005) Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun 73: 5450-5457. PMID: 16113261
7. Hill KK, Smith TJ, Helma CH, Ticknor LO, Foley BT, et al. (2007) Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol 189: 818-832. PMID: 17114256
8. Macdonald TE, Helma CH, Shou Y, Valdez YE, Ticknor LO, et al. (2011) Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl Environ Microbiol 77: 8625-8634. doi: 10.1128/AEM.05155-11 PMID: 22003031
9. Lúquez C, Raphael BH, Maslanka SE (2009) Neurotoxin gene clusters in Clostridium botulinum type Ab strains. Appl Environ Microbiol 75: 6094-6101. doi: 10.1128/AEM.01009-09 PMID: 19684172
10. Mazuet C, Ezan E, Volland H, Popoff MR, Becher F (2012) Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A botulism in France. J Clin Microbiol 50: 4091-4094. doi: 10.1128/JCM.02392-12 PMID: 22993181
11. Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S (2009) Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J Clin Microbiol 47: 2720-2728. doi: 10.1128/ JCM.00077-09 PMID: 19571018
12. Raphael BH, Choudoir MJ, Luquez C, Fernandez R, Maslanka SE (2010) Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol 76: 4805-4812. doi: 10.1128/AEM. 03109-09 PMID: 20511432
13. Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, et al. (2012) De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Anal Bioanal Chem 403: 215-226. doi: 10. 1007/s00216-012-5767-3 PMID: 22395449
14. Raphael BH, Lautenschlager M, Kalb SR, de Jong LI, Frace M, et al. (2012) Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype. BMC Microbiol 12: 245. doi: 10.1186/1471-2180-12-245 PMID: 23113872
15. Hill KK, Smith TJ (2013) Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol 364: 1-20. doi: 10.1007/978-3-642- 33570-9-1 PMID: 23239346
16. Wangroongsarb P, Kohda T, Jittaprasartsin C, Suthivarakom K, Kamthalang T, et al. (2014) Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010. PLoS One 9: e77792. doi: 10.1371/journal.pone.0077792 PMID: 24475015
17. Weedmark KA, Lambert DL, Mabon P, Hayden KL, Urfano CJ, et al. (2014) Two novel toxin variants revealed by whole-genome sequencing of 175 Clostridium botulinum type E strains. Appl Environ Microbiol 80: 6334-6345. doi: 10.1128/AEM.01573-14 PMID: 25107978
18. Moriishi K, Koura M, Abe N, Fujii N, Fujinaga Y, et al. (1996) Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim Biophys Acta 1307: 123-126. PMID: 8679691
19. Peck MW, Stringer SC, Carter AT (2011) Clostridium botulinum in the post-genomic era. Food Microbiol 28: 183-191. doi: 10.1016/j.fm.2010.03.005 PMID: 21315972
20. Krieglstein KG, DasGupta BR, Henschen AH (1994) Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains. J Protein Chem 13: 49-57. PMID: 8011071
21. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, et al. (1992) Tetanus and botulinum- B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359: 832-835. PMID: 1331807
22. Montecucco C, Schiavo G (1995) Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 28: 423-472. PMID: 8771234
23. Rummel A (2013) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 364: 61-90. doi: 10.1007/978-3-642-33570-9-4 PMID: 23239349
24. Pantano S, Montecucco C (2014) The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell Mol Life Sci 71: 793-811. doi: 10.1007/s00018-013-1380-7 PMID: 23749048
25. Rummel A, Mahrhold S, Bigalke H, Binz T (2004) The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 51: 631-643. PMID: 14731268
26. Stenmark P, Dupuy J, Imamura A, Kiso M, Stevens RC (2008) Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog 4: e1000129. doi: 10.1371/journal.ppat.1000129 PMID: 18704164
27. Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580: 2011-2014. PMID: 16545378
28. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, et al. (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312: 592-596. PMID: 16543415
29. Blasi J, Chapman ER, Yamasaki S, Binz T, Niemann H, et al. (1993) Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J 12: 4821-4828. PMID: 7901002
30. Schiavo G, Santucci A, Dasgupta BR, Mehta PP, Jontes J, et al. (1993) Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335: 99-103. PMID: 8243676
31. Foran P, Lawrence GW, Shone CC, Foster KA, Dolly JO (1996) Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35: 2630-2636. PMID: 8611567
32. Schiavo G, Rossetto O, Catsicas S, Polverino de Laureto P, DasGupta BR, et al. (1993) Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268: 23784-23787. PMID: 8226912
33. Schiavo G, Shone CC, Rossetto O, Alexander FC, Montecucco C (1993) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem 268: 11516-11519. PMID: 8505288
34. Yamasaki S, Binz T, Hayashi T, Szabo E, Yamasaki N, et al. (1994) Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem Biophys Res Commun 200: 829-835. PMID: 7910017
35. Arndt JW, Jacobson MJ, Abola EE, Forsyth CM, Tepp WH, et al. (2006) A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J Mol Biol 362: 733-742. PMID: 16938310
36. Gibson AM, Modi NK, Roberts TA, Shone CC, Hambleton P, et al. (1987) Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol 63: 217-226. PMID: 3323154
37. Gibson AM, Modi NK, Roberts TA, Hambleton P, Melling J (1988) Evaluation of a monoclonal antibodybased immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol 64: 285-291. PMID: 3049499
38. Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, et al. (2009) Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS ONE 4: e5355. doi: 10.1371/journal.pone.0005355 PMID: 19399171
39. Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, et al. (2011) Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti- BoNT/B antibodies. BMC Biochem 12: 58. doi: 10.1186/1471-2091-12-58 PMID: 22085466
40. Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, et al. (2009) Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 48: 2522-2528. doi: 10.1021/bi801686b PMID: 19256469
41. Wang D, Krilich J, Pellett S, Baudys J, Tepp WH, et al. (2013) Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5. Biochim Biophys Acta 1834: 2722-2728. doi: 10.1016/j. bbapap.2013.09.007 PMID: 24096023
42. Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, et al. (2012) Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett 586: 109-115. doi: 10.1016/j.febslet.2011.11.033 PMID: 22172278
43. Dorner MB, Schulz KM, Kull S, Dorner BG (2013) Complexity of botulinum neurotoxins: challenges for detection technology. Curr Top Microbiol Immunol 364: 219-255. doi: 10.1007/978-3-642-33570-9-11 PMID: 23239356
44. Kirchner S, Krämer KM, Schulze M, Pauly D, Jacob D, et al. (2010) Pentaplexed quantitative real-time PCR assay for the simultaneous detection and quantification of botulinum neurotoxin-producing clostridia in food and clinical samples. Appl Environ Microbiol 76: 4387-4395. doi: 10.1128/AEM. 02490-09 PMID: 20435756
45. Raphael BH, Joseph LA, McCroskey LM, Luquez C, Maslanka SE (2010) Detection and differentiation of Clostridium botulinum type A strains using a focused DNA microarray. Mol Cell Probes 24: 146-153. doi: 10.1016/j.mcp.2009.12.003 PMID: 20056143
46. Hill KK, Xie G, Foley BT, Smith TJ, Munk AC, et al. (2009) Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol 7: 66. doi: 10.1186/1741-7007-7-66 PMID: 19804621
47. Pauly D, Dorner M, Zhang X, Hlinak A, Dorner B, et al. (2009) Monitoring of laying capacity, immunoglobulin Y concentration, and antibody titer development in chickens immunized with ricin and botulinum toxins over a two-year period. Poult Sci 88: 281-290. doi: 10.3382/ps.2008-00323 PMID: 19151341
48. Pauly D, Kirchner S, Stoermann B, Schreiber T, Kaulfuss S, et al. (2009) Simultaneous quantification of five bacterial and plant toxins from complex matrices using a multiplexed fluorescent magnetic suspension assay. Analyst 134: 2028-2039. doi: 10.1039/b911525k PMID: 19768210
49. Stevens GB, Silver DA, Zgaga-Griesz A, Bessler WG, Vashist SK, et al. (2013) Bioluminescence assay for the highly sensitive detection of botulinum neurotoxin A activity. Analyst 138: 6154-6162. doi: 10. 1039/c3an00525a PMID: 23971072
50. Kalb SR, Garcia-Rodriguez C, Lou J, Baudys J, Smith TJ, et al. (2010) Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep- MS. PLoS ONE 5: e12237. doi: 10.1371/journal.pone.0012237 PMID: 20808925
51. Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, et al. (2011) Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel 24: 321-331. doi: 10.1093/protein/gzq111 PMID: 21149386
52. Carter AT, Paul CJ, Mason DR, Twine SM, Alston MJ, et al. (2009) Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum BMC Genomics 10: 115. doi: 10.1186/ 1471-2164-10-115 PMID: 19298644
53. Dover N, Barash JR, Arnon SS (2009) Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J Clin Microbiol 47: 2349-2350. doi: 10. 1128/JCM.00799-09 PMID: 19420169
54. Gu S, Rumpel S, Zhou J, Strotmeier J, Bigalke H, et al. (2012) Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335: 977-981. doi: 10.1126/science.1214270 PMID: 22363010
55. Lee K, Zhong X, Gu S, Kruel AM, Dorner MB, et al. (2014) Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344: 1405-1410. doi: 10.1126/science.1253823 PMID: 24948737
56. Giménez DF, Ciccarelli AS (1978) New strains of Clostridium botulinum subtype Af. Zentralbl Bakteriol Orig A 240: 215-220. PMID: 77604
57. Giménez DF, Cicarelli AS (1970) Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol Parasitenkd Infektionskr Abt 1 Orig Reihe A 215: 212-220. PMID: 4992024
58. Kalb SR, Baudys J, Smith TJ, Smith LA, Barr JR (2014) Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5. Anal Chem 86: 3254-3262. doi: 10.1021/ ac5001509 PMID: 24605815
59. Dover N, Barash JR, Hill KK, Davenport KW, Teshima H, et al. (2013) Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS One 8: e61205. doi: 10.1371/journal.pone.0061205 PMID: 23637798
60. Dover N, Barash JR, Hill KK, Xie G, Arnon SS (2014) Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis 209: 192-202. doi: 10.1093/infdis/jit450 PMID: 24106295
61. Smith TJ, Hill KK, Raphael BH (2014) Historical and current perspectives on Clostridium botulinum diversity. Res Microbiol. doi: 10.1016/j.resmic.2014.12.010 PMID: 25554489
62. van Ermengem E (1897) Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg 26: 1-56.
63. Landmann G (1904) Ueber die Ursache der Darmstädter Bohnenvergiftung. Hyg Rundsch 14: 449-452.
64. Leuchs J (1910) Beiträge zur Kenntnis des Toxins und Antitoxins des Bacillus botulinus. Z Hyg 65: 55-84.
65. Torii Y, Shinmura M, Kohda T, Kozaki S, Takahashi M, et al. (2013) Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin. Toxicon 73: 9-16. doi: 10.1016/j.toxicon.2013.06.020 PMID: 23834917
66. Whitemarsh RC, Tepp WH, Bradshaw M, Lin G, Pier CL, et al. (2013) Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro. Infect Immun 81: 3894-3902. doi: 10.1128/IAI.00536-13 PMID: 23918782
67. Mizanur RM, Stafford RG, Ahmed SA (2014) Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin. PLoS One 9: e95188. doi: 10.1371/journal.pone. 0095188 PMID: 24769566
68. Luo S, Li T, Wang Q, Tian R, Liu H, et al. (2014) Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins. Anal Biochem 463: 75-81. doi: 10.1016/j.ab.2013.06. 019 PMID: 23851341
69. Binz T, Bade S, Rummel A, Kollewe A, Alves J (2002) Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization. Biochemistry 41: 1717-1723. PMID: 11827515
70. Breidenbach MA, Brunger AT (2004) Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432: 925-929. PMID: 15592454
71. Segelke B, Knapp M, Kadkhodayan S, Balhorn R, Rupp B (2004) Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity. Proc Natl Acad Sci U S A 101: 6888-6893. PMID: 15107500
72. Bollenbach A (2013) Identifizierung der aktivitätsmindernen Aminosäuren der Botulinum Neurotoxin Subtypen A4 und A8 (Chemnitz Stamm): Leipniz Universität Hannover. 37 p.
73. Benoit RM, Frey D, Hilbert M, Kevenaar JT, Wieser MM, et al. (2014) Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Nature 505: 108-111. doi: 10.1038/ nature12732 PMID: 24240280
74. Strotmeier J, Mahrhold S, Krez N, Janzen C, Lou J, et al. (2014) Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A. FEBS Lett.
75. Muraro L, Tosatto S, Motterlini L, Rossetto O, Montecucco C (2009) The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. Biochem Biophys Res Commun 380: 76-80. doi: 10.1016/j.bbrc.2009.01.037 PMID: 19161982
76. Pier CL, Chen C, Tepp WH, Lin G, Janda KD, et al. (2011) Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett 585: 199-206. doi: 10.1016/j.febslet.2010.11.045 PMID: 21126520
77. Whitemarsh RC, Tepp WH, Johnson EA, Pellett S (2014) Persistence of botulinum neurotoxin A subtypes 1-5 in primary rat spinal cord cells. PLoS One 9: e90252. doi: 10.1371/journal.pone.0090252 PMID: 24587301
78. Torii Y, Akaike N, Harakawa T, Kato K, Sugimoto N, et al. (2011) Type A1 but not type A2 botulinum toxin decreases the grip strength of the contralateral foreleg through axonal transport from the toxintreated foreleg of rats. J Pharmacol Sci 117: 275-285. PMID: 22123262
79. Torii Y, Kiyota N, Sugimoto N, Mori Y, Goto Y, et al. (2011) Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test. Toxicon 57: 93-99. doi: 10. 1016/j.toxicon.2010.10.009 PMID: 21029745
80. Sebaihia M, Peck MW, Minton NP, Thomson NR, Holden MT, et al. (2007) Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res 17: 1082-1092. PMID: 17519437
81. Hall IC (1928) A collection of anaerobic bacteria. Science 68: 140-141. PMID: 17772244
82. Dineen SS, Bradshaw M, Karasek CE, Johnson EA (2004) Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum. FEMS Microbiol Lett 235: 9-16. PMID: 15158256
83. Thompson DE, Brehm JK, Oultram JD, Swinfield T- J, Shone CC, et al. (1990) The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem 189: 73-81. PMID: 2185020
84. Sakaguchi G, Sakaguchi S, Kamata Y, Tabita K, Asao T, et al. (1990) Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan. Int J Food Microbiol 11: 231-241. PMID: 2126444
85. White PB (1923) Report on the circumstances attending the deaths of eight persons from botulism at Loch Maree (Rossshire). Appendix I. Edinburgh, UK: Scottish Board of Health. 33-38 p.
86. Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, et al. (2007) Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS ONE 2: e1271. PMID: 18060065
87. Carter AT, Pearson BM, Crossman LC, Drou N, Heavens D, et al. (2011) Complete genome sequence of the proteolytic Clostridium botulinum type A5 (B30) strain H04402065. J Bacteriol 193: 2351-2352. doi: 10.1128/JB.00072-11 PMID: 21378191
88. Hatheway CL, McCroskey LM, Lombard GL, Dowell VR Jr. (1981) Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol 14: 607-611. PMID: 7037830
89. Dolman CE (1960) Type E botulism: A hazard of the north. Arctic 13: 230-256.
90. Møller V, Scheibel I (1960) Preliminary report on the isolation of an apparently new type of Cl. botulinum. Acta Pathol Microbiol Scand 48: 80. PMID: 14423425
91. Chevreux B (2005) MIRA: An automated genome and EST assembler. Heidelberg, Germany: Ruprecht-Karls-University. 171 p.
92. Katoh K, Misawa K, Kuma Ki, Miyata T (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30: 3059-3066. PMID: 12136088
93. Pier CL, Tepp WH, Bradshaw M, Johnson EA, Barbieri JT, et al. (2008) Recombinant holotoxoid vaccine against botulism. Infect Immun 76: 437-442. PMID: 17967862
94. Binz T, Blasi J, Yamasaki S, Baumeister A, Link E, et al. (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 269: 1617-1620. PMID: 8294407
95. Parks BA, Shearer JD, Baudys J, Kalb SR, Sanford DC, et al. (2011) Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry. Anal Chem 83: 9047-9053. doi: 10. 1021/ac201910q PMID: 22017298
96. Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5: 898-902. PMID: 9783750